Medtech Firm Extends 300% Surge on Cellulite, Tattoo Device Hope

(Bloomberg) -- Small-cap medical devicemaker Soliton Inc. shares extended their record week after U.S. regulators approved its tattoo removal device on Tuesday.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.